Huperzine A Complexed with Acetylcholinesterase
From Proteopedia
(Difference between revisions)
(6 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load='1vot' size='400' side='right' scene=' | + | <StructureSection load='1vot' size='400' side='right' scene='49/497129/Hup_in_ache/1' caption='Huperzine A complexed with AChE (PDP code [[1vot]])'> |
[[Image:1vot.jpg|left|200px]] | [[Image:1vot.jpg|left|200px]] | ||
Line 7: | Line 7: | ||
==Background== | ==Background== | ||
- | + | ||
- | <scene name='1vot/Huperzinea/2'>Huperzine A (HupA)</scene>, discovered by Chinese scientists from 1980s, has been proved to be a powerful, highly specific, and [http://en.wikipedia.org/wiki/Enzyme_inhibitor#Reversible_inhibitors reversible inhibitor] of [[acetylcholinesterase]] (AChE). It is a novel [http://en.wikipedia.org/wiki/Alkaloid alkaloid] originally isolated from the '''Traditional Chinese medicine''' [http://en.wikipedia.org/wiki/Traditional_Chinese_medicine] Qian Ceng Ta which is produced from the whole plant of the club moss [http://en.wikipedia.org/wiki/Huperzia_serrata ''Huperzia serrata'']. Qian Ceng Ta has been used for over 1000 years in China for treatment of [http://en.wikipedia.org/wiki/Bruise contusions], [http://en.wikipedia.org/wiki/Strain_(injury) strains], [http://en.wikipedia.org/wiki/Swelling_(medical) swellings], [http://en.wikipedia.org/wiki/Schizophrenia schizophrenia] and [http://en.wikipedia.org/wiki/Myasthenia_gravis myasthenia gravis]. Shuangyiping[http://www.54md.com/drugstore/pic/gpic_25fd25197010a0fb4a680516735e613c.jpg], a tablet form of HupA produced from the extracts of ''Huperzia serrata'', was developed in 1996 as a new drug for symptomatic treatment of Alzheimer’s disease in China. Compared with the other three [http://en.wikipedia.org/wiki/Food_and_Drug_Administration_(United_States) FDA]-approved drugs for the treatment of Alzheimer’s disease, Donepezil (Aricept, [[1eve]]), Rivastigmine (Exelon, [[1gqr]]), Galanthamine (Reminyl, [[1dx6]]), HupA has better penetration through the [http://en.wikipedia.org/wiki/Blood-brain_barrier blood-brain barrier], higher oral [http://en.wikipedia.org/wiki/Bioavailability bioavailability], and longer duration of AChE inhibitory action. | + | <scene name='1vot/Huperzinea/2'>Huperzine A (HupA)</scene>, discovered by Chinese scientists from 1980s, has been proved to be a powerful, highly specific, and [http://en.wikipedia.org/wiki/Enzyme_inhibitor#Reversible_inhibitors reversible inhibitor] of [[acetylcholinesterase]] (AChE). It is a novel [http://en.wikipedia.org/wiki/Alkaloid alkaloid] originally isolated from the '''Traditional Chinese medicine''' [http://en.wikipedia.org/wiki/Traditional_Chinese_medicine] Qian Ceng Ta which is produced from the whole plant of the club moss [http://en.wikipedia.org/wiki/Huperzia_serrata ''Huperzia serrata'']. [[Image:HuperzineA3.jpg|right|200px]] |
+ | Qian Ceng Ta has been used for over 1000 years in China for treatment of [http://en.wikipedia.org/wiki/Bruise contusions], [http://en.wikipedia.org/wiki/Strain_(injury) strains], [http://en.wikipedia.org/wiki/Swelling_(medical) swellings], [http://en.wikipedia.org/wiki/Schizophrenia schizophrenia] and [http://en.wikipedia.org/wiki/Myasthenia_gravis myasthenia gravis]. Shuangyiping[http://www.54md.com/drugstore/pic/gpic_25fd25197010a0fb4a680516735e613c.jpg], a tablet form of HupA produced from the extracts of ''Huperzia serrata'', was developed in 1996 as a new drug for symptomatic treatment of Alzheimer’s disease in China. Compared with the other three [http://en.wikipedia.org/wiki/Food_and_Drug_Administration_(United_States) FDA]-approved drugs for the treatment of Alzheimer’s disease, Donepezil (Aricept, [[1eve]]), Rivastigmine (Exelon, [[1gqr]]), Galanthamine (Reminyl, [[1dx6]]), HupA has better penetration through the [http://en.wikipedia.org/wiki/Blood-brain_barrier blood-brain barrier], higher oral [http://en.wikipedia.org/wiki/Bioavailability bioavailability], and longer duration of AChE inhibitory action. | ||
The structure of HupA shows some similarity to other known [[AChE inhibitors and substrates]]. The molecule is fairly rigid and contains an [http://en.wikipedia.org/wiki/Aromaticity aromatic] system as well as a [http://en.wikipedia.org/wiki/Amine primary amino group] that is probably [http://en.wikipedia.org/wiki/Protonation protonated] at physiological [http://en.wikipedia.org/wiki/PH pH]. Various suggestions have been made with respect to its orientation within the active site of AChE, and with respect to the amino acid residue with which its putative [http://en.wikipedia.org/wiki/Pharmacophore pharmacophoric] groups might interact. Solution of the 3D structure of a complex of HupA with AChE would permit unequivocal resolution of this issue and it would also provide a rational basis for structure-related [http://en.wikipedia.org/wiki/Drug_design drug design] aimed at developing synthetic analogues of HupA with improved therapeutic properties. | The structure of HupA shows some similarity to other known [[AChE inhibitors and substrates]]. The molecule is fairly rigid and contains an [http://en.wikipedia.org/wiki/Aromaticity aromatic] system as well as a [http://en.wikipedia.org/wiki/Amine primary amino group] that is probably [http://en.wikipedia.org/wiki/Protonation protonated] at physiological [http://en.wikipedia.org/wiki/PH pH]. Various suggestions have been made with respect to its orientation within the active site of AChE, and with respect to the amino acid residue with which its putative [http://en.wikipedia.org/wiki/Pharmacophore pharmacophoric] groups might interact. Solution of the 3D structure of a complex of HupA with AChE would permit unequivocal resolution of this issue and it would also provide a rational basis for structure-related [http://en.wikipedia.org/wiki/Drug_design drug design] aimed at developing synthetic analogues of HupA with improved therapeutic properties. | ||
Line 27: | Line 28: | ||
PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17644292 17644292] | PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17644292 17644292] | ||
- | See [[1vot (Chinese)]]. | ||
+ | [[zh:Huperzine_A_Complexed_with_Acetylcholinesterase (Chinese)]] | ||
+ | [[en:Huperzine_A_Complexed_with_Acetylcholinesterase]] | ||
+ | |||
+ | <!-- name=32/3203/ --> | ||
[[Category: Acetylcholinesterase]] | [[Category: Acetylcholinesterase]] | ||
[[Category: Single protein]] | [[Category: Single protein]] |
Current revision
|
Reference
Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A., Raves ML, Harel M, Pang YP, Silman I, Kozikowski AP, Sussman JL, Nat. Struct. Biol. 1997 Jan;4(1):57-63. PMID:8989325
Huperzine A from Huperzia species-An ethnopharmacolgical review., Ma X, Tan C, Zhu D, Gang D, Xiao P, J. Ethnopharmacol. 2007 Aug;113(1):15-34. PMID:17644292
Created with the participation of Yechun Xu, Joel L. Sussman, David Canner, Jaime Prilusky, Eran Hodis.
Proteopedia Page Contributors and Editors (what is this?)
Joel L. Sussman, Alexander Berchansky, Michal Harel, Jaime Prilusky